Pr Fabrice Bauer (@normandicc) 's Twitter Profile
Pr Fabrice Bauer

@normandicc

Advanced Heart Failure and Pulmonary Hypertension. Structural Heart Failure Disease. Cardiac Amylodosis

ID: 1446078594543931399

calendar_today07-10-2021 11:43:38

112 Tweet

55 Followers

39 Following

Radcliffe Cardiology (@radcliffecardio) 's Twitter Profile Photo

During this new podcast episode, we hear how primary care is ideally positioned to provide early screening and detection of HF – even if practitioners do not consider themselves HF specialists – and how this is key to alleviating the current levels of clinical inertia.

Felice Gragnano (@felicegragnano) 's Twitter Profile Photo

On May 26, the U.S. FDA approved #sotagliflozin, the first dual SGLT-1/2 inhibitor for #HF treatment (regardless of EF). 🆕 study evaluated the eligibility for sotagliflozin in a real-world 🇸🇪 population ⤵️ academic.oup.com/ehjcvp/article… #EHJPharmacotherapy Stefan Agewall European Society of Cardiology Journals

On May 26, the <a href="/US_FDA/">U.S. FDA</a> approved #sotagliflozin, the first dual SGLT-1/2 inhibitor for #HF treatment (regardless of EF). 🆕 study evaluated the eligibility for sotagliflozin in a real-world 🇸🇪 population ⤵️
academic.oup.com/ehjcvp/article…

#EHJPharmacotherapy <a href="/AgewallStefan/">Stefan Agewall</a> <a href="/ESC_Journals/">European Society of Cardiology Journals</a>
HFAPresident (@hfa_president) 's Twitter Profile Photo

I'm beyond excited to announce the Clinical Trials in HF Course. 3 Days. Learn how to: ▶️ how to design trials ▶️ how to analyze data ▶️ how to read correct literature ▶️ practice Giuseppe Rosano Marco Metra Antonio Cannata' Sotiria Liori Amina Gianluigi Savarese Mehmet Birhan YILMAZ 🇹🇷

I'm beyond excited to announce the Clinical Trials in HF Course. 3 Days. Learn how to:
▶️ how to design trials
▶️ how to analyze data
▶️ how to read correct literature 
▶️ practice
<a href="/GMCRosano/">Giuseppe Rosano</a> <a href="/MarcoMetra/">Marco Metra</a> <a href="/_antocannata/">Antonio Cannata'</a> <a href="/SotiriaLiori/">Sotiria Liori</a> <a href="/ARakisheva/">Amina</a> <a href="/GianluSava/">Gianluigi Savarese</a> <a href="/cardioceptor/">Mehmet Birhan YILMAZ 🇹🇷</a>
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired & iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. Read more on PVS in #JACC: bit.ly/3CvKapJ

Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired &amp; iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. Read more on PVS in #JACC: bit.ly/3CvKapJ
Jean-Michel Tartière (@drjmtartiere) 's Twitter Profile Photo

Rapport de la cours des comptes sur la mise en place des #IPA en 2023 Sans surprise 2 freins majeurs 1️⃣opposition active ou passive de beaucoup de médecins 2️⃣conséquence directe un modèle économique non viable ccomptes.fr/fr/publication… UNIPA Sarah Marini @DevictorJulie

Rapport de la cours des comptes sur la mise en place des #IPA en 2023
Sans surprise 2 freins majeurs 1️⃣opposition active ou passive de beaucoup de médecins
2️⃣conséquence directe un modèle économique non viable
ccomptes.fr/fr/publication…
<a href="/Syndicat_UNIPA/">UNIPA</a> <a href="/SarahMarini8/">Sarah Marini</a> @DevictorJulie
Ryan J Tedford MD (@ryantedfordmd) 's Twitter Profile Photo

🔥🔥First LBCT session of #THT2025 - Javed Butler shares 2 year outcome data from the ALT-FLOW single-arm EFS. Significant ⬆️ in KCCQ, 6MWD and ⬇️in NYHA FC. Stable RA/RV size/function. Similar improvements in those with PVR < or > 2 WU. Sim pub JACC Journals:

🔥🔥First LBCT session of #THT2025 - <a href="/JavedButler1/">Javed Butler</a> shares 2 year outcome data from the ALT-FLOW single-arm EFS.  
Significant ⬆️ in KCCQ, 6MWD and ⬇️in NYHA FC.  Stable RA/RV size/function.  Similar improvements in those with PVR &lt; or &gt; 2 WU.  Sim pub <a href="/JACCJournals/">JACC Journals</a>:
Circulation (@circaha) 's Twitter Profile Photo

A visionary in structural heart disease & interventional echocardiography, Dr. Rebecca T. Hahn has revolutionized valve imaging & percutaneous therapies. Her impact on research, training & innovation is unmatched. Read her inspiring path to discovery! ahajournals.org/doi/full/10.11…

A visionary in structural heart disease &amp; interventional echocardiography, Dr. Rebecca T. Hahn has revolutionized valve imaging &amp; percutaneous therapies. Her impact on research, training &amp; innovation is unmatched. Read her inspiring path to discovery! ahajournals.org/doi/full/10.11…
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25. Check out the key findings ➡️ bit.ly/3DYGHEl

Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25.

Check out the key findings ➡️ bit.ly/3DYGHEl
Harriette Van Spall, MD MPH 🇨🇦 (@hvanspall) 's Twitter Profile Photo

In this RCT of 1766 patients with #cancer and history of #VTE, extended apixaban 2.5 mg bid was non-inferior (NIF margin 2.0 for upper 95% CI) to apixaban 5.0 mg bid in preventing recurrent VTE Hierarchical testing demonstrated superiority in ⬇️bleeding #APICAT #ACC25

In this RCT of 1766 patients with #cancer and history of #VTE, extended apixaban 2.5 mg bid was non-inferior (NIF margin 2.0 for upper 95% CI) to apixaban 5.0 mg bid in preventing recurrent VTE 
Hierarchical testing demonstrated superiority in ⬇️bleeding 
#APICAT #ACC25
American College of Cardiology (@accintouch) 's Twitter Profile Photo

ALIGN-AR: Among patients with aortic regurgitation undergoing #TAVR with the Trilogy valve, the rate of mortality at one year was 8.1%, significantly lower than the prespecified goal of 25% to show noninferiority. #ACC25 Learn more: bit.ly/4l9TWTr

ALIGN-AR: Among patients with aortic regurgitation undergoing #TAVR with the Trilogy valve, the rate of mortality at one year was 8.1%, significantly lower than the prespecified goal of 25% to show noninferiority. #ACC25

Learn more: bit.ly/4l9TWTr
Circulation (@circaha) 's Twitter Profile Photo

#ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity & decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. ahajrnls.org/4c9VokJ #AHAJournals RTHahnMD Samir Kapadia

#ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity &amp; decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. ahajrnls.org/4c9VokJ #AHAJournals <a href="/hahn_rt/">RTHahnMD</a> <a href="/tavrkapadia/">Samir Kapadia</a>
EJHF Editor-in-Chief (@ejhfeic) 's Twitter Profile Photo

Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the #HFA of the European Society of Cardiology Marco Metra onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF Henry Han Amr Abdin Giuseppe Galati

Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the #HFA of the <a href="/escardio/">European Society of Cardiology</a> 

<a href="/MarcoMetra/">Marco Metra</a> 

onlinelibrary.wiley.com/doi/10.1002/ej… 

#EJHF <a href="/HanCardiomd/">Henry Han</a> <a href="/AmrAbdin10/">Amr Abdin</a> <a href="/GiuseppeGalati_/">Giuseppe Galati</a>
American College of Cardiology (@accintouch) 's Twitter Profile Photo

“With an ever-growing population of #HeartFailure patients, it seems counterintuitive that fewer cardiology fellows are pursuing careers in this field,” writes Stephanie Golob, MD, in a recent #CardiologyMag article. Read more: bit.ly/4k3XmVT #ACCFIT

“With an ever-growing population of #HeartFailure patients, it seems counterintuitive that fewer cardiology fellows are pursuing careers in this field,” writes Stephanie Golob, MD, in a recent #CardiologyMag article.

Read more: bit.ly/4k3XmVT #ACCFIT